Sometimes it takes two. Two breast cancer medications, that is.

Androgen deprivation therapy (ADT) for men with prostate cancer might make their bones weak. Fortunately, a common medication can make them strong again — if patients can get a prescription.

The risk of broken bones increases with age and is a major cause of disability and death in older people. But some treatments may prevent bone fractures.

Bisphosphonates are a class of medications commonly used to prevent bone loss and osteoporosis. Now, it seems these medications might have an additional benefit: protection against certain cancers.

Fractures and weak bones are common in patients with Crohn’s disease. So researchers recently set out to find out what happens when these patients take bone-protecting medicines early on.

Detection of osteoporosis is important for treating and preventing bone fractures. But when it comes to bone density testing for osteoporosis, more isn’t always better.

Past studies have raised concerns that a type of osteoporosis drug may boost the risk of unusual bone fractures. Now research suggests this risk may be overstated.

A class of drugs known as bisphosphonates has received some bad press lately. These drugs, used to strengthen bones and treat bone metastasis, are linked with a number of health conditions. The association with cancer has expanded.

They're designed to strengthen bones. This class of drugs known as bisphosphorates is also prescribed to cancer patients to treat excessive calcium in the blood. These drugs can actually increase the risks of unusual bone fractures.

Multiple myeloma  is a cancer of the blood cells. It grows in the bone marrow, and can cause long bones like the thigh bone (femur) and bones in the spine to break. Drug therapy with a class of drugs can help to prevent these fractures.